F
Clovis Oncology, Inc. CLVSQ
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Net Income -56.02M -71.33M -60.17M -64.39M -67.41M
Total Depreciation and Amortization 1.89M 1.90M 1.92M 2.00M 2.02M
Total Amortization of Deferred Charges 566.00K 561.00K 558.00K 554.00K 616.00K
Total Other Non-Cash Items 6.76M 15.50M 7.00M 7.57M 6.39M
Change in Net Operating Assets 6.20M 18.24M -7.81M 12.93M 12.31M
Cash from Operations -40.61M -35.13M -58.50M -41.34M -46.07M
Capital Expenditure -89.00K -46.00K -62.00K -69.00K -89.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -89.00K -46.00K -62.00K -69.00K -89.00K
Total Debt Issued 6.18M 8.76M 9.22M 9.73M 10.58M
Total Debt Repaid -- -- -- 0.00 -64.42M
Issuance of Common Stock 0.00 384.00K 28.64M 3.44M 41.52M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00 0.00
Cash from Financing 6.18M 9.14M 37.86M 13.17M -12.33M
Foreign Exchange rate Adjustments -1.74M -1.63M -487.00K -276.00K 229.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -36.26M -27.66M -21.19M -28.52M -58.26M
Weiss Ratings